Remicade Biosimilar Market

Demand for Remicade biosimilar will increase through 2036, with rheumatoid arthritis at a 43.2% share as the leading indication segment. The market value stood at USD 2.3 billion in 2025 and is forecast to reach USD 4.1 billion by 2036 across key growth regions including China, India, and Germany.